LAYN is a key gene in the regulation of immunity, and a bioinformatics analysis showed that LAYN is associated with prognosis and the level of immune infiltration of CD8+ T cells, CD4+ T cells, macrophages, neutrophils, and DCs in patients with several cancers, especially colon and gastric cancers. The gene discussed is CD4; the disease is cancer.